<DOC>
	<DOCNO>NCT02964455</DOCNO>
	<brief_summary>The phase I study determine maximum tolerate dose dose limit toxicity docetaxel nedaplatin prescribe twice weekly combination concurrent chest radiotherapy patient locally advanced esophageal squamous cell carcinoma .</brief_summary>
	<brief_title>Study Concurrent Chemoradiotherapy Locally Advanced Esophageal Squamous Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<criteria>Histologically confirm esophageal squamous cell carcinoma Inoperable stage IIIVa ( UICC 2002 ; sixth edition ) , confirm contrast enhance computed tomography , endoscopic ultrasonography , barium esophagram , emission compute tomography and/or positron emission tomography/computed tomography . Eastern Cooperative Oncology Group ( ECOG ) performance status 12 Estimated life expectancy least 12 week Charlson comorbidity index≤4 Adequate bone marrow function : white blood cell grade 0 1 , absolute neutrophil grade 0 1 , platelet grade 0 , haemoglobin grade 0 1 Adequate renal function : creatinine grade 0 1 Adequate liver function : serum bilirubin grade 0 1 , alanine aminotransferase aspartate aminotransferase &lt; 2 time upper normal limit Weight loss≤15 % 6 month prior diagnosis Forced expiratory volume second≥1L Prior history malignancy , except nonmelanoma skin carcinoma cervical carcinoma situ Previous antitumor therapy , include surgery , chemotherapy radiotherapy Contraindication chemotherapy radiotherapy Malignant pleural pericardial effusion Women pregnancy lactation period Women probability pregnancy without contraception Weight loss≥15 % 3 month prior diagnosis In clinical trial within 30 day Addicted drug alcohol , AIDS patient Uncontrollable seizure psychotic patient without selfcontrol ability Severe allergy idiosyncrasy Not suitable study judge researcher</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Esophageal squamous cell carcinoma</keyword>
	<keyword>Chemoradiotherapy</keyword>
	<keyword>Docetaxel</keyword>
	<keyword>Nedaplatin</keyword>
	<keyword>Twice weekly</keyword>
</DOC>